Many people who have type 2 diabetes live with uncontrolled disease before they are diagnosed, the experts explained. Diabetic retinopathy is the leading reason behind blindness among working-age Americans, according to the U.S. National Vision Institute . The eye disease affects 8 million people in the usa nearly, the NEI said. Programs with lower co-payments and deductibles are creating lower aggregate cost, as evidenced by a nationwide proceed to medical homes and employer-sponsored on-site health treatment centers with lower deductibles and co-obligations. Ross, who has 20 years experience in worker benefits, conducted an evaluation of 200,000 program users covered under multiple company self-funded health programs. The two-year analysis looked at claims totaling $800 million.As of October 22, 2012, landmark survival at 6, 9, 12, and 18 months was 65 percent, 44 percent, 33 percent, and 17 percent respectively. There is apparently no difference in survival between the two groups. The National Comprehensive Malignancy Network Guidelines cite historical 12 month survival data of 0-22 percent with single agent therapy in recurrent cervical malignancy. This study shows 12 month survival of 33 percent among several 70 patients. 6 complete responses and 6 partial responses have already been reported, an increase of one complete response since our July report. 6 complete responses : 4 in the ADXS alone group; 2 in the ADXS+ cisplatin group. 6 partial responses : 3 in the ADXS alone group; 3 in the ADXS+ cisplatin group. After 110 patients and 264 doses, the protection data is certainly encouraging.